These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Local recurrence of rectal cancer: MR imaging before and after oral superparamagnetic particles vs contrast-enhanced computed tomography. Blomqvist L, Ohlsén H, Hindmarsh T, Jonsson E, Holm T. Eur Radiol; 2000 Jul; 10(9):1383-9. PubMed ID: 10997424 [Abstract] [Full Text] [Related]
16. Superparamagnetic particles as oral contrast medium in MR imaging of malignant lymphoma. Lönnemark M, Hemmingsson A, Bach-Gansmo T, Hagberg H, Magnusson A, Gundersen HG, Nyman R. Acta Radiol; 1991 May; 32(3):232-8. PubMed ID: 2064867 [Abstract] [Full Text] [Related]
17. Oral magnetic particles as a contrast agent for MR imaging of the abdomen. A phase III clinical trial. Vlahos L, Gouliamos A, Kalovidouris A, Athanasopoulou A, Kotoulas G, Lygidakis N, Liaou A, Matsaidonis D, Papavasiliou C. Hepatogastroenterology; 1994 Feb; 41(1):82-5. PubMed ID: 8175124 [Abstract] [Full Text] [Related]
19. A multisite phase III study of the safety and efficacy of a new manganese chloride-based gastrointestinal contrast agent for MRI of the abdomen and pelvis. Small WC, DeSimone-Macchi D, Parker JR, Sukerkar A, Hahn PF, Rubin DL, Zelch JV, Kuhlman JE, Outwater EK, Weinreb JC, Brown JJ, de Lange EE, Woodward PJ, Arildsen R, Foster GS, Runge VM, Aisen AM, Muroff LR, Thoeni RF, Parisky YR, Tanenbaum LN, Totterman S, Herfkens RJ, Knudsen J, Bernardino ME. J Magn Reson Imaging; 1999 Jul; 10(1):15-24. PubMed ID: 10398973 [Abstract] [Full Text] [Related]
20. Oral magnetic particles. Results from clinical phase II trials in 216 patients. Oksendal AN, Bach-Gansmo T, Jacobsen TF, Eide H, Andrew E. Acta Radiol; 1993 Mar; 34(2):187-93. PubMed ID: 8452728 [Abstract] [Full Text] [Related] Page: [Next] [New Search]